Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 4

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 4
---
 our leadership position in artificial intelligence (“AI”) through obtaining AI-enabled U.S. Food and Drug Administration authorizations, developing cloud-based solutions, and developing foundation models to simplify AI integration in healthcare.

In 2024, we demonstrated our commitment to our disciplined mergers and acquisitions strategy, complementing existing technologies and solutions. We closed on two acquisitions, resulting in the additions of MIM Software, with AI-enabled image analysis and workflow tools, and Intelligent Ultrasound, adding innovative, real-time image recognition technology. We also announced the acquisition of the remaining 50% stake in Nihon Medi-Physics to deepen our radiopharmaceutical distribution capabilities in Japan and other Asian markets. We deliver the smart devices and drugs that help customers solve for disease states across the patient journey, and digital and AI-powered technologies that unlock the power of data to help clinicians make more informed decisions, enabling better patient outcomes.

Our strategy prioritizes the following pillars:

| Precision care                                         
 Connected care pathways and digitization of healthcare |     | Growth acceleration                            
 Commercial capabilities and product leadership |     | Business Optimization                             
 Sustainable margin expansion and strong cash flow |

#### 4GE HEALTHCARE 2025 PROXY STATEMENT

#### Proxy Statement Summary

#### Compensation
Our executive compensation program is designed to attract, retain, and motivate top executive talent who create long-term value for our stockholders through execution of our business strategy. Our pay program is market-competitive, aligned with stockholder interests, and driven by strong governance practices for sound decision-making. Highlights of our executive compensation and governance practices include:

• A total rewards philosophy and guiding principles that serve as a clear and transparent framework for considering compensation designs and individual pay levels

• An executive compensation program designed to strengthen the link between pay and performance by having a significant portion of total executive compensation at-risk, performance-based, and long-term focused

• Use of a balanced mix of cash and equity and annual and long-term incentives

• Annual and long-term incentive plans that incorporate business-focused goals, which are complementary, risk-balancing, and designed to encourage an ownership-oriented team

• Robust governance practices, including stock ownership requirements, a clawback policy (with mandatory and discretionary components), prohibitions on hedging and pledging, and annual risk assessments

• Proactive stockholder outreach to understand their perspectives and views on our executive compensation program and philosophy

#### GE HEALTHCARE 2025 PROXY STATEMENT5

#### Proxy Statement Summary

#### Director Nominees
The Nominating and Governance Committee (